Ipilimumab and serous retinal detachment
Medicines Safety Update
- Erenumab and hypertensionMedicines Safety Review
- Sertraline and microscopic colitisHealth professionals are advised that the Product Information (PI) documents for sertraline have been updated to include microscopic colitis as a potential adverse effect of unknown frequency based on post-marketing experience.
- Ocrelizumab and late onset neutropeniaThe Product Information for ocrelizumab has been updated to include a warning and further information about late onset neutropenia.